FDA Import Refusal AEK-1314188-0/11/1 — ASTRAZENECA UK LTD
The FDA refused shipment AEK-1314188-0/11/1 from ASTRAZENECA UK LTD (United Kingdom) on Jul 14, 2022. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jul 14, 2022
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75